Pharmaceuticals

2014-2026 Global Hereditary Angioedema Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

SKU ID :Maia-14973639 | Published Date: 06-Dec-2019 | No. of pages: 110

Description

The worldwide market for Hereditary Angioedema is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in

Major Region

s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
iBio
Sanofi N.V.
Pharming Group
Merck & Co., Inc.
Cipla, Inc.
Ionis Pharmaceuticals
Shire
CSL
ioCryst Pharmaceuticals
Teva Pharmaceutical Industries

Major Types Covered
Type I HAE
Type II HAE
Type III HAE

Major Applications Covered
Hospitals
clinics
Research centers

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…